FDA Inspection 695835 — Teva Pharmaceutical Industries
The FDA completed an inspection of Teva Pharmaceutical Industries on September 16, 2010 in Jerusalem. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 16, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jerusalem (Israel)